Global Molecular Influenza Diagnostic Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID: GIR2201050245 | Category: Medical Devices & Consumables | Pages: 101 | Format: PDF | Published Date: July 11,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Molecular Influenza Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Molecular Influenza Diagnostic market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during review period. Hospitals accounting for  % of the Molecular Influenza Diagnostic global market in 2021, is projected to value USD  million by 2028, growing at a  % CAGR in next six years. While Reverse Transcription Polymerase Chain Reaction (RT-PCR) segment is altered to a  % CAGR between 2022 and 2028.
Global key companies of Molecular Influenza Diagnostic include BD, Abbott (Include Alere), Roche, SIEMENS, and Analytik Jena, etc. In terms of revenue, the global top four players hold a share over  % in 2021.
Market segmentation
Molecular Influenza Diagnostic market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Reverse Transcription Polymerase Chain Reaction (RT-PCR)
    Nucleic Acid Sequence Based Amplification (NASBA) Tests
    Loop-mediated Isothermal Amplification-Based Assays (LAMP)
    Simple Amplification-based Assays (SAMBA)
Market segment by Application, can be divided into
    Hospitals
    POCT
    Others
Market segment by players, this report covers
    BD
    Abbott (Include Alere)
    Roche
    SIEMENS
    Analytik Jena
    Quidel
    Thermo Fisher
    Meridian Bioscience
    BioMerieux
    Sekisui Diagnostics
    Response Biomedical
    SA Scientific
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Molecular Influenza Diagnostic product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Molecular Influenza Diagnostic, with revenue, gross margin and global market share of Molecular Influenza Diagnostic from 2019 to 2022.
Chapter 3, the Molecular Influenza Diagnostic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Molecular Influenza Diagnostic market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Molecular Influenza Diagnostic research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Product Overview and Scope of Molecular Influenza Diagnostic
    1.2 Classification of Molecular Influenza Diagnostic by Type
        1.2.1 Overview: Global Molecular Influenza Diagnostic Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Molecular Influenza Diagnostic Revenue Market Share by Type in 2021
        1.2.3 Reverse Transcription Polymerase Chain Reaction (RT-PCR)
        1.2.4 Nucleic Acid Sequence Based Amplification (NASBA) Tests
        1.2.5 Loop-mediated Isothermal Amplification-Based Assays (LAMP)
        1.2.6 Simple Amplification-based Assays (SAMBA)
    1.3 Global Molecular Influenza Diagnostic Market by Application
        1.3.1 Overview: Global Molecular Influenza Diagnostic Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Hospitals
        1.3.3 POCT
        1.3.4 Others
    1.4 Global Molecular Influenza Diagnostic Market Size & Forecast
    1.5 Global Molecular Influenza Diagnostic Market Size and Forecast by Region
        1.5.1 Global Molecular Influenza Diagnostic Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Molecular Influenza Diagnostic Market Size by Region, (2017-2022)
        1.5.3 North America Molecular Influenza Diagnostic Market Size and Prospect (2017-2028)
        1.5.4 Europe Molecular Influenza Diagnostic Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Molecular Influenza Diagnostic Market Size and Prospect (2017-2028)
        1.5.6 South America Molecular Influenza Diagnostic Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Molecular Influenza Diagnostic Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Molecular Influenza Diagnostic Market Drivers
        1.6.2 Molecular Influenza Diagnostic Market Restraints
        1.6.3 Molecular Influenza Diagnostic Trends Analysis
2 Company Profiles
    2.1 BD
        2.1.1 BD Details
        2.1.2 BD Major Business
        2.1.3 BD Molecular Influenza Diagnostic Product and Solutions
        2.1.4 BD Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 BD Recent Developments and Future Plans
    2.2 Abbott (Include Alere)
        2.2.1 Abbott (Include Alere) Details
        2.2.2 Abbott (Include Alere) Major Business
        2.2.3 Abbott (Include Alere) Molecular Influenza Diagnostic Product and Solutions
        2.2.4 Abbott (Include Alere) Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Abbott (Include Alere) Recent Developments and Future Plans
    2.3 Roche
        2.3.1 Roche Details
        2.3.2 Roche Major Business
        2.3.3 Roche Molecular Influenza Diagnostic Product and Solutions
        2.3.4 Roche Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Roche Recent Developments and Future Plans
    2.4 SIEMENS
        2.4.1 SIEMENS Details
        2.4.2 SIEMENS Major Business
        2.4.3 SIEMENS Molecular Influenza Diagnostic Product and Solutions
        2.4.4 SIEMENS Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 SIEMENS Recent Developments and Future Plans
    2.5 Analytik Jena
        2.5.1 Analytik Jena Details
        2.5.2 Analytik Jena Major Business
        2.5.3 Analytik Jena Molecular Influenza Diagnostic Product and Solutions
        2.5.4 Analytik Jena Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Analytik Jena Recent Developments and Future Plans
    2.6 Quidel
        2.6.1 Quidel Details
        2.6.2 Quidel Major Business
        2.6.3 Quidel Molecular Influenza Diagnostic Product and Solutions
        2.6.4 Quidel Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Quidel Recent Developments and Future Plans
    2.7 Thermo Fisher
        2.7.1 Thermo Fisher Details
        2.7.2 Thermo Fisher Major Business
        2.7.3 Thermo Fisher Molecular Influenza Diagnostic Product and Solutions
        2.7.4 Thermo Fisher Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Thermo Fisher Recent Developments and Future Plans
    2.8 Meridian Bioscience
        2.8.1 Meridian Bioscience Details
        2.8.2 Meridian Bioscience Major Business
        2.8.3 Meridian Bioscience Molecular Influenza Diagnostic Product and Solutions
        2.8.4 Meridian Bioscience Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Meridian Bioscience Recent Developments and Future Plans
    2.9 BioMerieux
        2.9.1 BioMerieux Details
        2.9.2 BioMerieux Major Business
        2.9.3 BioMerieux Molecular Influenza Diagnostic Product and Solutions
        2.9.4 BioMerieux Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 BioMerieux Recent Developments and Future Plans
    2.10 Sekisui Diagnostics 
        2.10.1 Sekisui Diagnostics Details
        2.10.2 Sekisui Diagnostics Major Business
        2.10.3 Sekisui Diagnostics Molecular Influenza Diagnostic Product and Solutions
        2.10.4 Sekisui Diagnostics Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Sekisui Diagnostics Recent Developments and Future Plans
    2.11 Response Biomedical
        2.11.1 Response Biomedical Details
        2.11.2 Response Biomedical Major Business
        2.11.3 Response Biomedical Molecular Influenza Diagnostic Product and Solutions
        2.11.4 Response Biomedical Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Response Biomedical Recent Developments and Future Plans
    2.12 SA Scientific
        2.12.1 SA Scientific Details
        2.12.2 SA Scientific Major Business
        2.12.3 SA Scientific Molecular Influenza Diagnostic Product and Solutions
        2.12.4 SA Scientific Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 SA Scientific Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Molecular Influenza Diagnostic Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Molecular Influenza Diagnostic Players Market Share in 2021
        3.2.2 Top 10 Molecular Influenza Diagnostic Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Molecular Influenza Diagnostic Players Head Office, Products and Services Provided
    3.4 Molecular Influenza Diagnostic Mergers & Acquisitions
    3.5 Molecular Influenza Diagnostic New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Molecular Influenza Diagnostic Revenue and Market Share by Type (2017-2022)
    4.2 Global Molecular Influenza Diagnostic Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Molecular Influenza Diagnostic Revenue Market Share by Application (2017-2022)
    5.2 Global Molecular Influenza Diagnostic Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
    6.1 North America Molecular Influenza Diagnostic Revenue by Type (2017-2028)
    6.2 North America Molecular Influenza Diagnostic Revenue by Application (2017-2028)
    6.3 North America Molecular Influenza Diagnostic Market Size by Country
        6.3.1 North America Molecular Influenza Diagnostic Revenue by Country (2017-2028)
        6.3.2 United States Molecular Influenza Diagnostic Market Size and Forecast (2017-2028)
        6.3.3 Canada Molecular Influenza Diagnostic Market Size and Forecast (2017-2028)
        6.3.4 Mexico Molecular Influenza Diagnostic Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
    7.1 Europe Molecular Influenza Diagnostic Revenue by Type (2017-2028)
    7.2 Europe Molecular Influenza Diagnostic Revenue by Application (2017-2028)
    7.3 Europe Molecular Influenza Diagnostic Market Size by Country
        7.3.1 Europe Molecular Influenza Diagnostic Revenue by Country (2017-2028)
        7.3.2 Germany Molecular Influenza Diagnostic Market Size and Forecast (2017-2028)
        7.3.3 France Molecular Influenza Diagnostic Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Molecular Influenza Diagnostic Market Size and Forecast (2017-2028)
        7.3.5 Russia Molecular Influenza Diagnostic Market Size and Forecast (2017-2028)
        7.3.6 Italy Molecular Influenza Diagnostic Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Molecular Influenza Diagnostic Revenue by Type (2017-2028)
    8.2 Asia-Pacific Molecular Influenza Diagnostic Revenue by Application (2017-2028)
    8.3 Asia-Pacific Molecular Influenza Diagnostic Market Size by Region
        8.3.1 Asia-Pacific Molecular Influenza Diagnostic Revenue by Region (2017-2028)
        8.3.2 China Molecular Influenza Diagnostic Market Size and Forecast (2017-2028)
        8.3.3 Japan Molecular Influenza Diagnostic Market Size and Forecast (2017-2028)
        8.3.4 South Korea Molecular Influenza Diagnostic Market Size and Forecast (2017-2028)
        8.3.5 India Molecular Influenza Diagnostic Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Molecular Influenza Diagnostic Market Size and Forecast (2017-2028)
        8.3.7 Australia Molecular Influenza Diagnostic Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
    9.1 South America Molecular Influenza Diagnostic Revenue by Type (2017-2028)
    9.2 South America Molecular Influenza Diagnostic Revenue by Application (2017-2028)
    9.3 South America Molecular Influenza Diagnostic Market Size by Country
        9.3.1 South America Molecular Influenza Diagnostic Revenue by Country (2017-2028)
        9.3.2 Brazil Molecular Influenza Diagnostic Market Size and Forecast (2017-2028)
        9.3.3 Argentina Molecular Influenza Diagnostic Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Molecular Influenza Diagnostic Revenue by Type (2017-2028)
    10.2 Middle East & Africa Molecular Influenza Diagnostic Revenue by Application (2017-2028)
    10.3 Middle East & Africa Molecular Influenza Diagnostic Market Size by Country
        10.3.1 Middle East & Africa Molecular Influenza Diagnostic Revenue by Country (2017-2028)
        10.3.2 Turkey Molecular Influenza Diagnostic Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Molecular Influenza Diagnostic Market Size and Forecast (2017-2028)
        10.3.4 UAE Molecular Influenza Diagnostic Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Molecular Influenza Diagnostic Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?